Brief: Tenax Announces Issuance Of U.S. Patent Covering Use Of Iv Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction (Ph-Hfpef)

Tenax Therapeutics

22/03/2023 12:55

March 22 (Reuters) - Tenax Therapeutics Inc  TENX.O :
    * TENAX ANNOUNCES ISSUANCE OF U.S. PATENT COVERING USE OF IV
LEVOSIMENDAN IN PULMONARY HYPERTENSION WITH HEART FAILURE WITH
PRESERVED EJECTION FRACTION (PH-HFPEF)
    * TENAX THERAPEUTICS INC - PATENT PROVIDES INTELLECTUAL
PROPERTY
PROTECTION UNTIL DECEMBER 2040

Source text for Eikon:  ID:nGNX2qvtLg 
Further company coverage:  TENX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))